Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol

Description

The purpose of this study is to develop a secure method of collecting physiologic information from patients with cancer. The researchers will use this information to learn more about how physiologic data may relate to cancer diagnosis and response to treatment, and to identify factors that may lead to higher or lower risk of cancer.

Conditions

Solid Tumor

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to develop a secure method of collecting physiologic information from patients with cancer. The researchers will use this information to learn more about how physiologic data may relate to cancer diagnosis and response to treatment, and to identify factors that may lead to higher or lower risk of cancer.

Remote Digital Physiological Data Collection in Cancer: An MSK Registry Protocol

Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol

Condition
Solid Tumor
Intervention / Treatment

-

Contacts and Locations

New York

Memorial Sloan Kettering Cancer Center, New York, New York, United States, 10065

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Individuals who meet at least one of the following criteria:
  • * Diagnosis of new onset early-stage (I-III), low-grade (I-II), or locally advanced solid tumor within 24 months of initial recruitment approach
  • * Diagnosis of primary invasive solid tumor from 2015 onwards
  • * Diagnosis of metastatic (stage IV) or high-grade (III-IV) disease
  • * Enrolled onto an investigational trial in the EDD Service
  • * Seen in the MSK UCC from 2021 and onwards
  • * Completion of Baseline Medical History (BMH) Questionnaire
  • * Adult without a history of cancer \<50 years of age
  • * Adult without a history of cancer ≥ 50 years of age
  • * 18 to 90 years old
  • * Own an Apple iPhone with valid iOS operating software
  • * Have the MyMSK app downloaded on their iPhone or be willing to download the MyMSK app
  • * Willing to provide informed consent
  • * Self-reported "very well" comprehension of written and verbal English language
  • * Patients at MSK who are:
  • * Scheduled to undergo any type of BMT (Cohort 1)
  • * Diagnosed with new onset AML and scheduled to initiate antineoplastic therapy (Cohort 2)
  • * Scheduled to undergo any surgery for prostate cancer (Cohort 3)
  • * Scheduled to undergo any lung cancer surgery (Cohort 4)
  • * Scheduled to undergo TNT for locally advanced rectal cancer (Cohort 5)
  • * Scheduled to initiate androgen deprivation therapy for at least 12 months and has one of the following prostate cancer diagnoses (Cohort 6):
  • * High risk/very high localized, locally advanced,
  • * Biochemically recurrent prostate cancer
  • * Treatment naïve, low-volume metastatic prostate cancer
  • * Scheduled Scheduled to undergo chemotherapy for metastatic pancreatic cancer (Cohort 7)
  • * Individuals without cancer \<50 years of age (Cohort 8)
  • * Individuals without cancer ≥50 years of age (Cohort 9)
  • * 18 to 90 years old at the time of consent
  • * Willing and able to download the Withings Health Mate app onto their personal mobile device
  • * Willing to provide mobile digital physiological data for a period of at least six months to a maximum of one year following consent
  • * Willing to provide informed consent
  • * Unable or unwilling to successfully export and share physiological data
  • * Unable or unwilling to appropriately use digital platforms or devices

Ages Eligible for Study

18 Years to 90 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Memorial Sloan Kettering Cancer Center,

Lee Jones, PhD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

2025-05